These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20437013)

  • 1. Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).
    Rades D; Setter C; Dunst J; Dahl O; Schild SE; Noack F
    Strahlenther Onkol; 2010 Jun; 186(6):307-14. PubMed ID: 20437013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer.
    Rades D; Setter C; Dahl O; Schild SE; Noack F
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of VEGF and VEGF receptor 1 (FLT1) expression on the prognosis of stage III esophageal cancer patients after radiochemotherapy.
    Rades D; Golke H; Schild SE; Kilic E
    Strahlenther Onkol; 2008 Aug; 184(8):416-20. PubMed ID: 18956519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.
    Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F; Rades D
    Strahlenther Onkol; 2013 Aug; 189(8):639-46. PubMed ID: 23748230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.
    Firat S; Bousamra M; Gore E; Byhardt RW
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1047-57. PubMed ID: 11958901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery.
    Taylor NA; Liao ZX; Stevens C; Walsh G; Roth J; Putnam J; Fossella F; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):616-25. PubMed ID: 12788166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiotherapy in radically resected non-small cell lung cancer.
    Mayer R; Smolle-Juettner FM; Szolar D; Stuecklschweiger GF; Quehenberger F; Friehs G; Hackl A
    Chest; 1997 Oct; 112(4):954-9. PubMed ID: 9377958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumor.
    Yamane Y; Ishii G; Goto K; Kojima M; Nakao M; Shimada Y; Nishiwaki Y; Nagai K; Kohrogi H; Ochiai A
    J Thorac Oncol; 2010 Jan; 5(1):49-55. PubMed ID: 20035185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to treatment in patients with stage III non-small cell lung cancer.
    Wang L; Correa CR; Hayman JA; Zhao L; Cease K; Brenner D; Arenberg D; Curtis J; Kalemkerian GP; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):790-5. PubMed ID: 19231108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
    Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
    Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.
    Maggi G; Casadio C; Cianci R; Oliaro A; Molinatti M; Bretti S; Clerico M; Boidi-Trotti A; Rovea P
    J Cardiovasc Surg (Torino); 1994 Aug; 35(4):341-6. PubMed ID: 7929550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
    Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
    Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.
    Moretti L; Yu DS; Chen H; Carbone DP; Johnson DH; Keedy VL; Putnam JB; Sandler AB; Shyr Y; Lu B
    Oncologist; 2009 Nov; 14(11):1106-15. PubMed ID: 19897534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancer.
    Jones DR; Moskaluk CA; Gillenwater HH; Petroni GR; Burks SG; Philips J; Rehm PK; Olazagasti J; Kozower BD; Bao Y
    J Thorac Oncol; 2012 Nov; 7(11):1683-90. PubMed ID: 23059775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.
    Werner-Wasik M; Scott C; Cox JD; Sause WT; Byhardt RW; Asbell S; Russell A; Komaki R; Lee JS
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1475-82. PubMed ID: 11121651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
    Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
    J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Lee HW; Noh OK; Oh YT; Choi JH; Chun M; Kim HI; Heo J; Ahn MS; Park SY; Park RW; Yoon D
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):621-7. PubMed ID: 26867891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.